Characterization of corpus cavernosum smooth muscle cell phenotype in diabetic rats with erectile dysfunction

International Journal of Impotence Research

Volumn 24, Issue 5, 2012, Pages 196-201

  Wei, A Y ^a   He, S H ^a   Zhao, J F ^b   Liu, Y ^a   Hu, Y W ^a   Zhang, T ^a   Wu, Z Y ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Henan Province Hospital of Traditional Chinese Medicine   (China)

Author keywords

diabetes mellitus; erectile dysfunction; smooth muscle

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; APOMORPHINE; CALPONIN; MESSENGER RNA; MYOCARDIN; MYOSIN HEAVY CHAIN; SMOOTHELIN; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DIABETES MELLITUS; ERECTILE DYSFUNCTION; MALE; NONHUMAN; PENIS ERECTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER; TISSUE LEVEL; WESTERN BLOTTING;

ACTINS; ANIMALS; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; CYTOSKELETAL PROTEINS; DIABETES MELLITUS, EXPERIMENTAL; ERECTILE DYSFUNCTION; GENE EXPRESSION; MALE; MICROFILAMENT PROTEINS; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE, SMOOTH; MYOSIN HEAVY CHAINS; NUCLEAR PROTEINS; PENIS; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATORS;

EID: 84866420077     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2012.16     Document Type: Article

References (28)

1. Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 2005; 47: 80-86.
2. Cho NH, Ahn CW, Park JY, Ahn TY, Lee HW, Park TS et al. Prevalence of erectile dysfunction in Korean men with type 2 diabetes mellitus. Diabet Med 2006; 23: 198-203.
3. Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med 2009; 6: 1232-1247.
4. Kapoor D, Clarke S, Channer KS, Jones TH. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes. Int J Androl 2007; 30: 500-507.
5. Roth A, Kalter-Leibovici O, Kerbis Y, Tenenbaum-Koren E, Chen J, Sobol T et al. Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: A community survey among 1,412 Israeli men. Clin Cardiol 2003; 26: 25-30.
6. Burchardt T, Burchardt M, Karden J, Buttyan R, Shabsigh A, de la Taille A et al. Reduction of endothelial and smooth muscle density in the corpora cavernosa of the streptozotocin induced diabetic rat. J Urol 2000; 164: 1807-1811.
7. Ferrini MG, Kovanecz I, Sanchez S, Umeh C, Rajfer J, Gonzalez-Cadavid NF. Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal venoocclusive dysfunction (cvod) induced by experimental cavernosal nerve damage in the rat. J Sex Med 2009; 6: 415-428.
8. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004; 84: 767-801.
9. Orr AW, Lee MY, Lemmon JA, Yurdagul Jr A, Gomez MF, Bortz PD et al. Molecular mechanisms of collagen isotype-specific modulation of smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 2009; 29: 225-231.
10. Rzucidlo EM, Martin KA, Powell RJ. Regulation of vascular smooth muscle cell differentiation. J Vasc Surg 2007; 45(Suppl A): A25-A32.
11. Kovanecz I, Nolazco G, Ferrini MG, Toblli JE, Heydarkhan S, Vernet D et al. Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction. BJU Int 2009; 103: 1396-1404.
12. Wei AY, Cheng Y, Li YG. Phenotype modulation of smooth muscle in corpus cavernosum in penis tunica albuginea in diabetes mellitus with erectile dysfunction: Experiment with rats. Zhonghua Yi Xue Za Zhi 2007; 87: 3006-3011 (in Chinese).
13. Yang R, Wang J, Chen Y, Sun Z, Wang R, Dai Y. Effect of caffeine on erectile function via up-regulating cavernous cyclic guanosine monophosphate in diabetic rats. J Androl 2008; 29: 586-591.
14. Chen Y, Li SX, Yao LS, Wang R, Dai YT. Valsartan treatment reverses erectile dysfunction in diabetic rats. Int J Impot Res 2007; 19: 366-370.
15. Heaton JP, Varrin SJ, Morales A. The characterization of a bio-assay of erectile function in a rat model. J Urol 1991; 145: 1099-1102.
16. Pilatz A, Schultheiss D, Gabouev AI, Schlote N, Mertsching H, Jonas U et al. Isolation of primary endothelial and stromal cell cultures of the corpus cavernosum penis for basic research and tissue engineering. Eur Urol 2005; 47: 710-719.
17. Kropp BP, Zhang Y, Tomasek JJ, Cowan R, Furness III PD, Vaughan MB et al. Characterization of cultured bladder smooth muscle cells: Assessment of in vitro contractility. J Urol 1999; 162: 1779-1784.
18. Rensen SS, Doevendans PA, van Eys GJ. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J 2007; 15: 100-108.
19. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q et al. Microrna-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009; 105: 158-166.
20. Neuville P, Geinoz A, Benzonana G, Redard M, Gabbiani F, Ropraz P et al. Cellular retinol-binding protein-1 is expressed by distinct subsets of rat arterial smooth muscle cells in vitro and in vivo. Am J Pathol 1997; 150: 509-521.
21. Beamish JA, Fu AY, Choi AJ, Haq NA, Kottke-Marchant K, Marchant RE. The influence of rgd-bearing hydrogels on the re-expression of contractile vascular smooth muscle cell phenotype. Biomaterials 2009; 30: 4127-4135.
22. Hungerford JE, Owens GK, Argraves WS, Little CD. Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Dev Biol 1996; 178: 375-392.
23. Miano JM, Cserjesi P, Ligon KL, Periasamy M, Olson EN. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res 1994; 75: 803-812.
24. Zhang X, Kanika ND, Melman A, Disanto ME. Smooth muscle myosin expression, isoform composition and functional activities in rat corpus cavernosum altered by the streptozotocin-induced type 1 diabetes. Am J Physiol Endocrinol Metab 2012; 302: E32-E42.
25. Saleem MA, Zavadil J, Bailly M, McGee K, Witherden IR, Pavenstadt H et al. The molecular and functional phenotype of glomerular podocytes reveals key features of contractile smooth muscle cells. Am J Physiol Renal Physiol 2008; 295: F959-F970.
26. Parekh A, Long RA, Iannone EC, Chancellor MB, Sacks MS. Assessing the effects of transforming growth factor-beta1 on bladder smooth muscle cell phenotype. I. Modulation of in vitro contractility. J Urol 2009; 182: 1210-1215.
27. Hao H, Gabbiani G, Bochaton-Piallat ML. Arterial smooth muscle cell heterogeneity: Implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 2003; 23: 1510-1520.
28. Long X, Bell RD, Gerthoffer WT, Zlokovic BV, Miano JM. Myocardin is sufficient for a smooth muscle-like contractile phenotype. Arterioscler Thromb Vasc Biol 2008; 28: 1505-1510.